204 related articles for article (PubMed ID: 7532011)
1. Differential activation of Gi and Gs proteins by E- and I-type prostaglandins in membranes from the human erythroleukaemia cell line, HEL.
Schwaner I; Offermanns S; Spicher K; Seifert R; Schultz G
Biochim Biophys Acta; 1995 Feb; 1265(1):8-14. PubMed ID: 7532011
[TBL] [Abstract][Full Text] [Related]
2. The prostacyclin analogues, cicaprost and iloprost, increase cytosolic Ca2+ concentration in the human erythroleukemia cell line, HEL, via pertussis toxin-insensitive G-proteins.
Schwaner I; Seifert R; Schultz G
Eicosanoids; 1992; 5 Suppl():S10-2. PubMed ID: 1280455
[TBL] [Abstract][Full Text] [Related]
3. Receptor-mediated increases in cytosolic Ca2+ in the human erythroleukaemia cell line involve pertussis toxin-sensitive and -insensitive pathways.
Schwaner I; Seifert R; Schultz G
Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):301-7. PubMed ID: 1310589
[TBL] [Abstract][Full Text] [Related]
4. Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum.
Lawrence RA; Jones RL; Wilson NH
Br J Pharmacol; 1992 Feb; 105(2):271-8. PubMed ID: 1559125
[TBL] [Abstract][Full Text] [Related]
5. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
6. Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques.
Sharif NA; Davis TL
J Pharm Pharmacol; 2002 Apr; 54(4):539-47. PubMed ID: 11999132
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E receptors in myometrial cells.
Asbóth G; Phaneuf S; López Bernal AL
Acta Physiol Hung; 1997-1998; 85(1):39-50. PubMed ID: 9530435
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
9. Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice.
Minami T; Nishihara I; Uda R; Ito S; Hyodo M; Hayaishi O
Br J Pharmacol; 1994 Jul; 112(3):735-40. PubMed ID: 7921597
[TBL] [Abstract][Full Text] [Related]
10. Role of prostanoid IP and EP receptors in mediating vasorelaxant responses to PGI2 analogues in rat tail artery: Evidence for Gi/o modulation via EP3 receptors.
Orie NN; Clapp LH
Eur J Pharmacol; 2011 Mar; 654(3):258-65. PubMed ID: 21185823
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
Matthews JS; Jones RL
Br J Pharmacol; 1993 Feb; 108(2):363-9. PubMed ID: 8448586
[TBL] [Abstract][Full Text] [Related]
12. [Cooperation of two subtypes of PGE2 receptor, Gi coupled EP3 and Gs coupled EP2 or EP4 subtype].
Hatae N
Yakugaku Zasshi; 2003 Oct; 123(10):837-43. PubMed ID: 14577329
[TBL] [Abstract][Full Text] [Related]
13. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
Watanabe T; Satoh H; Togoh M; Taniguchi S; Hashimoto Y; Kurokawa K
J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208
[TBL] [Abstract][Full Text] [Related]
14. 7,7-Difluoroprostacyclin derivative, AFP-07, a highly selective and potent agonist for the prostacyclin receptor.
Chang CS; Negishi M; Nakano T; Morizawa Y; Matsumura Y; Ichikawa A
Prostaglandins; 1997 Feb; 53(2):83-90. PubMed ID: 9112287
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein.
Lawrence RA; Jones RL
Br J Pharmacol; 1992 Apr; 105(4):817-24. PubMed ID: 1324050
[TBL] [Abstract][Full Text] [Related]
16. Selective coupling of prostaglandin E receptor EP3D to Gi and Gs through interaction of alpha-carboxylic acid of agonist and arginine residue of seventh transmembrane domain.
Negishi M; Irie A; Sugimoto Y; Namba T; Ichikawa A
J Biol Chem; 1995 Jul; 270(27):16122-7. PubMed ID: 7608175
[TBL] [Abstract][Full Text] [Related]
17. Translocation of alpha subunits of stimulatory guanine nucleotide-binding proteins through stimulation of the prostacyclin receptor in mouse mastocytoma cells.
Negishi M; Hashimoto H; Ichikawa A
J Biol Chem; 1992 Feb; 267(4):2364-9. PubMed ID: 1370818
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues.
Dong YJ; Jones RL; Wilson NH
Br J Pharmacol; 1986 Jan; 87(1):97-107. PubMed ID: 2420404
[TBL] [Abstract][Full Text] [Related]
19. Prostanoid receptor with a novel pharmacological profile in human erythroleukemia cells.
Feoktistov I; Breyer RM; Biaggioni I
Biochem Pharmacol; 1997 Oct; 54(8):917-26. PubMed ID: 9354592
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandins E2 and I2 downregulate tumor necrosis factor alpha-induced intercellular adhesion molecule-1 expression in human oral gingival epithelial cells.
Noguchi K; Iwasaki K; Endo H; Kondo H; Shitashige M; Ishikawa I
Oral Microbiol Immunol; 2000 Oct; 15(5):299-304. PubMed ID: 11154420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
